Clinical Trial Update: Reducing Barriers to Lifestyle Modification for Newly Diagnosed MASLD [NA]

View source ↗

Summary

A Stanford-sponsored clinical trial update describes efforts to reduce barriers to lifestyle modification for people newly diagnosed with metabolic dysfunction-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: Stanford University | Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease | NA | Status: NOT_YET_RECRUITING